A Decade of Asthma Care in Primary Care in Kuwait: Trends in Utilization, Prescribing, and the Reliever-to-Controller Ratio

Read the full article

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background. Kuwait carries one of the highest asthma burdens in the Gulf region, with adult prevalence of 11-15% and childhood prevalence of 18%. Most patients rely on government-funded primary care. In 2014, the primary care clinic serving Yarmouk, Kuwait’s first WHO-designated Healthy City, operated from an outdated asthma protocol with no on-site spirometry, no spacer devices, and a controller formulary limited to beclomethasone and montelukast. Objective. To describe changes in asthma-related primary care activity and prescribing over a decade of cumulative clinical and environmental quality improvement, and to evaluate the reliever-to-controller prescribing ratio (R:C) as a candidate national quality metric derivable from routine electronic health record data. Methods. Retrospective longitudinal analysis of 135 consecutive months (January 2015-March 2026) of aggregate monthly data from the national Primary Care Information (PCI) system at Abdalla Al Abdul Hadi Clinic, Yarmouk. Outcomes were asthma-coded visits (absolute and as a proportion of all clinic visits), the R:C ratio, and ambient air quality indicators. Temporal trends were estimated by linear regression with Newey-West standard errors, a three-segment interrupted time series, and seasonal harmonic adjustment. The significance level was α = 0.05. Results. Asthma’s share of clinic visits fell from 1.81% (2016-2018 mean) to 1.02% (2025), a 44% relative reduction (β = -0.007 percentage points/month, p < 0.001). The R:C ratio declined monotonically from 2.77 (2015) to 0.78 (2025), a 72% reduction, crossing below 1.0 in 2023 (β = -0.015/month, R² = 0.79). The largest single-year drop (-26%) occurred between 2018 and 2019, coinciding with the clinic’s protocol revision and the GINA 2019 recommendation against reliever-only treatment. During the COVID-19 lockdown, the asthma-visit proportion rose rather than fell (β = +0.494, p = 0.007), inconsistent with the hypothesis that reduced ambient pollution explained the simultaneous drop in absolute visit counts. Structured patient education delivery rose 3.4-fold (0.82% to 2.81% of visits; β = +0.026/month, p < 0.001). Hospital referrals declined in absolute terms but not per 100 asthma visits. Conclusions. Over a decade, prescribing at this clinic shifted from reliever- to controller-dominated care, and asthma’s proportional share of primary care activity fell by 44%. No single intervention can be isolated as causal. The R:C ratio is proposed as a simple, PCI-derivable metric for national benchmarking of asthma care quality, and the COVID analysis illustrates why proportional (not absolute) outcomes are essential when interpreting trends from routinely collected data.

Article activity feed